Investigating the effect of c‐Myc inhibitors at a concentration of 25 μM on A549 lung cancer cells revealed that four compounds c‐Myc‐i6, c‐Myc‐i7, c‐Myc‐i8 and c‐Myc‐i10 significantly reduced cell viability by at least 30%, similar to the reference compound 10058‐F4 (Figure 1A). Here, MYC is linked to lung carcinoma.